top of page

PUBLICATIONS

References and Links to Papers

VOLUME 2 - APRIL 2023

Published April 4th, 2023

Co-author: Dr. Oliver Kuljis

SPIMS HDVD+AID SLE&AA.jpg

ABSTRACT

Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that affects multiple organs and systems in the body. Alopecia areata (AA) is an autoimmune disease characterized by hair loss in patches on the scalp and other parts of the body. Here we report a case of a 35-year-old female patient from Brazil with SLE who developed AA and was successfully treated with the LGS Protocol.

​

The patient presented with intense polyarthralgia with swelling and was diagnosed with SLE. She was treated with hydroxychloroquine, methotrexate, and prednisone, which led to symptom improvement for two years. However, the patient later had a relapse of SLE symptoms and developed AA. Intralesional corticosteroid injections were administered to the scalp, resulting in hair regrowth in patches. However, 20 months later, the patient had another relapse of AA, which was more intense.

 

The patient learned about the LGS Protocol, which involves a high dose of vitamin D and anti-inflammatory diet. She began treatment and noticed significant improvement in joint pain after only three weeks. Hair growth was also noticeable after four months, and the patient achieved complete remission after one year on the protocol.

This case highlights the potential benefit of the LGS Protocol for the treatment of autoimmune diseases such as SLE and AA.

Published April 6th, 2023

ABSTRACT

Diabetes is a chronic metabolic disease that affects millions of people worldwide. The prevalence of diabetes has been increasing rapidly, with estimates projecting that 783 million people worldwide will have diabetes by 2045. The United States has also seen a significant rise in diabetes cases, with over 34 million people living with the disease.

​

This article presents a clinical case of a 48-year-old male patient with a 10-year history of diabetes and hyperlipidemia, who was insulin dependent and taking metformin and atorvastatin. Despite these medications, the patient's A1C was 9.5, and his doctor was considering increasing his insulin dose. Additionally, the patient reported experiencing peripheral neuropathy and chronic pain in his lower extremities and behind his knees.

​

The patient reached out to Dr. Eduardo Beltran and was introduced to the protocol and underwent a 12-month period treatment with the LGS Protocol, which involved taking 50,000 IU of vitamin D3 daily, along with cofactors and 600 mg of alpha-lipoic acid BID. The patient was able to lose over 45 pounds during this period and continues to do so. Medications were gradually discontinued. By month 4, the patient no longer required any medications and continued taking only the supplements of the protocol. After 12 months into the protocol, his A1C was significantly reduced to 5.6. The patient is now in complete remission.

​

This case study highlights the potential benefits of a holistic approach to managing diabetes, which focuses on lifestyle modifications, diet, and natural interventions. The LGS Protocol, which emphasizes the importance of adequate vitamin D levels, alpha-lipoic acid, and healthy eating habits, has shown promising results in helping patients achieve better outcomes. These findings suggest that a comprehensive approach to diabetes management may be a viable alternative to traditional medications and help patients achieve long-term remission.

Screen Shot 2023-04-06 at 2.28.03 PM.png

Published April 10th, 2023

HDVD+AID CD Pic.jpg
ABSTRACT

Crohn's disease is a chronic inflammatory bowel disease that affects the gastrointestinal tract, causing a range of symptoms such as abdominal pain, diarrhea, and weight loss. It is estimated to affect around 3 million people worldwide, with a higher incidence in developed countries. This abstract describes the clinical case of a 27-year-old patient diagnosed with Crohn's disease in 2014, who was treated with conventional immunosuppressive drugs such as mesalazine, azathioprine, and mercaptopurine from 2015 to 2022. During this time, the patient experienced several intestinal complications, requiring two partial intestinal resections and recurring anal fistulas. Despite regular antibiotic use, the patient's diet was not addressed by the attending physicians.

In 2022, the patient learned about high dose vitamin D therapy (HDVD) and anti-inflammatory diet (AID) as an alternative solution for his condition. He began taking 50,000 IU of D3 a day and after one month into the protocol, he felt 90% better with less bloating, better appetite, better sleep, and overall improved health. The patient has been on the protocol for a whole year, and all of his inflammatory biomarkers have improved, and he is currently in remission. This case highlights the potential benefits of a personalized approach to Crohn's disease treatment, including diet and high-dose
bottom of page